Company Overview of Baliopharm GmbH
Baliopharm GmbH develops protein therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and cancer. The company is based in Juelich, Germany. As of May 18, 2016, Baliopharm GmbH operates as a subsidiary of ALVOTECH.
49 2461 6210 855
49 2461 6216 687
Key Executives for Baliopharm GmbH
Baliopharm GmbH does not have any Key Executives recorded.
Similar Private Companies By Industry
|4 Animals AlsterScience GmbH||Europe|
|Acousia Therapeutics GmbH||Europe|
|Across Barriers GmbH||Europe|
|Actinodrug Pharmaceuticals GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Baliopharm GmbH, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.